Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Remote activation of enzyme nanohybrids for cancer prodrug therapy controlled by magnetic heating

  • Torres-Herrero, B.
  • Armenia, I.
  • Alleva, M.
  • Asín, L.
  • Correa, S.
  • Ortiz, C.
  • Fernández-Afonso, Y.
  • Gutiérrez, L.
  • Martínez De la Fuente, J.
  • Betancor, L.
  • Grazú, V.
Herein, we have developed nanohybrids (nHs) to remotely activate a therapeutic enzyme for its use in Directed Enzyme Prodrug Therapy (DEPT). The coencapsulation of magnetic nanoparticles (MNPs) with horseradish peroxidase (HRP) using biomimetic silica as an entrapment matrix was optimized to obtain nanosized hybrids (∼150 nm) for remote activation of the therapeutic enzyme. HRP converts indole-3-acetic acid (3IAA) into peroxylated radicals, whereas MNPs respond to alternating magnetic fields (AMFs) becoming local hotspots. The AMF application triggered an increase in the bioconversion rate of HRP matching the activity displayed at the optimal temperature of the nHs (Topt = 50 °C) without altering the temperature of the reaction media. This showed that enzyme nanoactuation is possible with MNPs even if they are not covalently bound. After an extensive physicochemical/magnetic characterization, the spatial location of each component of the nH was deciphered, and an insulating role of the silica matrix was suggested as critical for introducing remote control over HRP. In vitro assays, using a human pancreatic cancer cell line (MIA PaCa-2), showed that only upon exposure to AMF and in the presence of the prodrug, the enzyme-loaded nHs triggered cell death. Moreover, in vivo experiments showed higher reductions in the tumor volume growth in those animals treated with nHs in the presence of 3IAA when exposed to AMF. Thus, this work demonstrates the feasibility of developing a spatiotemporally controlled DEPT strategy to overcome unwanted off-target effects.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Opportunities for nanomaterials in enzyme therapy

  • Torres-Herrero, Beatriz
  • Armenia, Ilaria
  • Ortiz, Cecilia
  • Martínez de la Fuente, Jesús
  • Betancor, Lorena
  • Grazú, Valeria
In recent years, enzyme therapy strategies have rapidly evolved to catalyze essential biochemical reactions with therapeutic potential. These approaches hold particular promise in addressing rare genetic disorders, cancer treatment, neurodegenerative conditions, wound healing, inflammation management, and infectious disease control, among others. There are several primary reasons for the utilization of enzymes as therapeutics: their substrate specificity, their biological compatibility, and their ability to generate a high number of product molecules per enzyme unit. These features have encouraged their application in enzyme replacement therapy where the enzyme serves as the therapeutic agent to rectify abnormal metabolic and physiological processes, enzyme prodrug therapy where the enzyme initiates a clinical effect by activating prodrugs, and enzyme dynamic or starving therapy where the enzyme acts upon host substrate molecules. Currently, there are >20 commercialized products based on therapeutic enzymes, but approval rates are considerably lower than other biologicals. This has stimulated nanobiotechnology in the last years to develop nanoparticle-based solutions that integrate therapeutic enzymes. This approach aims to enhance stability, prevent rapid clearance, reduce immunogenicity, and even enable spatio-temporal activation of the therapeutic catalyst. This comprehensive review delves into emerging trends in the application of therapeutic enzymes, with a particular emphasis on the synergistic opportunities presented by incorporating enzymes into nanomaterials. Such integration holds the promise of enhancing existing therapies or even paving the way for innovative nanotherapeutic approaches.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Cr3+-Doped γ- and β-Gallium Oxide Nanoprobes for Bioimaging: Synthesis, Persistent Luminescence, and Biocompatibility

  • Arroyo, Encarnación
  • Monje-Moreno, José M.
  • Torres-Herrero, Beatriz
  • Munoz, Manuel J.
  • Martínez de la Fuente, Jesús
  • Becerro, Ana I.
  • Ocaña, Manuel
Persistent luminescent (PersL) nanophosphors that emit in the near infrared (NIR) region are promising nanoprobes for in vivo bioimaging. Although Cr3+‐doped zinc gallate nanoparticles (NPs) have been widely studied as in vivo bioimaging nanoprobes due to their NIR PersL emission at 695 nm, the simpler Cr3+‐doped gallium oxide system has been less explored despite its deeper NIR emission (760 nm), which favors tissue penetration. This is likely due the lack of synthesis methods that render Ga2O3‐based NPs suitable for in vivo applications. In this paper, a novel method for the synthesis of uniform and hydrophilic γ‐Ga2O3:Cr3+ NPs is reported, whose photoluminescence (PL) and PersL are optimized by adjusting their Cr3+ content. Such properties are further greatly improved through an annealing process at high temperature, which result in the transformation of its crystal structure into the β‐phase. The obtained β‐Ga2O3:Cr3+ NPs are colloidally stable in a physiological pH simulator medium and are nontoxic for cells. Finally, this work studies, for the first time in literature, the in vivo biocompatibility of such NPs using a Caenorhabditis elegans (C. elegans) animal model, finding that their morbidity and reproductive toxicity are negligible. In summary, the reported NPs are excellent candidates for their use as a NIR PersL probes for in vivo bioimaging.